178 related articles for article (PubMed ID: 32931196)
1. Use of Angiotensin II in Severe Vasoplegia After Left Pneumonectomy Requiring Cardiopulmonary Bypass: A Renin Response Analysis.
Trethowan B; Michaud CJ; Fifer S
Crit Care Med; 2020 Oct; 48(10):e912-e915. PubMed ID: 32931196
[TBL] [Abstract][Full Text] [Related]
2. Treatment With Angiotensin II Is Associated With Rapid Blood Pressure Response and Vasopressor Sparing in Patients With Vasoplegia After Cardiac Surgery: A Post-Hoc Analysis of Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) Study.
Klijian A; Khanna AK; Reddy VS; Friedman B; Ortoleva J; Evans AS; Panwar R; Kroll S; Greenfeld CR; Chatterjee S
J Cardiothorac Vasc Anesth; 2021 Jan; 35(1):51-58. PubMed ID: 32868152
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.
Wieruszewski PM; Radosevich MA; Kashani KB; Daly RC; Wittwer ED
J Cardiothorac Vasc Anesth; 2019 Nov; 33(11):3080-3084. PubMed ID: 31060933
[No Abstract] [Full Text] [Related]
4. Evaluating the evidence for angiotensin II for the treatment of vasoplegia in critically ill cardiothoracic surgery patients.
Chow JH; Wittwer ED; Wieruszewski PM; Khanna AK
J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1407-1414. PubMed ID: 33875258
[No Abstract] [Full Text] [Related]
5. Plasma Renin Activity Increases With Cardiopulmonary Bypass and is Associated With Vasoplegia After Cardiac Surgery.
Montgomery ML; Gross CR; Lin HM; Ouyang Y; Levin MA; Corkill HE; El-Eshmawi A; Adams DH; Weiner MM
J Cardiothorac Vasc Anesth; 2023 Mar; 37(3):367-373. PubMed ID: 36509636
[TBL] [Abstract][Full Text] [Related]
6. A Pilot Study of Renin-Guided Angiotensin-II Infusion to Reduce Kidney Stress After Cardiac Surgery.
Sadjadi M; von Groote T; Weiss R; Strauß C; Wempe C; Albert F; Langenkämper M; Landoni G; Bellomo R; Khanna AK; Coulson T; Meersch M; Zarbock A
Anesth Analg; 2024 Jul; 139(1):165-173. PubMed ID: 38289858
[TBL] [Abstract][Full Text] [Related]
7. Renin-angiotensin-aldosterone system dynamics after targeted blood pressure control using angiotensin II or norepinephrine in cardiac surgery: mechanistic randomised controlled trial.
Coulson TG; Miles LF; Zarbock A; Burrell LM; Patel SK; von Groote T; Pilcher D; Weinberg L; Landoni G; Bellomo R
Br J Anaesth; 2023 Oct; 131(4):664-672. PubMed ID: 37481435
[TBL] [Abstract][Full Text] [Related]
8. Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome.
Evans A; McCurdy MT; Weiner M; Zaku B; Chow JH
Ann Thorac Surg; 2019 Jul; 108(1):e5-e7. PubMed ID: 30582924
[TBL] [Abstract][Full Text] [Related]
9. When All Else Fails: Novel Use of Angiotensin II for Vasodilatory Shock: A Case Report.
Chow JH; Galvagno SM; Tanaka KA; Mazzeffi MA; Chancer Z; Henderson R; McCurdy MT
A A Pract; 2018 Oct; 11(7):175-180. PubMed ID: 29688923
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and Postoperative Vasopressor Use in Cardiopulmonary Bypass.
Javorski MJ; Kerolos MM; Fareed J; Perez-Tamayo RA
Clin Appl Thromb Hemost; 2018 Nov; 24(8):1322-1326. PubMed ID: 29730947
[TBL] [Abstract][Full Text] [Related]
11. Vitamin C for Vasoplegia After Cardiopulmonary Bypass: A Case Series.
Wieruszewski PM; Nei SD; Maltais S; Schaff HV; Wittwer ED
A A Pract; 2018 Aug; 11(4):96-99. PubMed ID: 29634537
[TBL] [Abstract][Full Text] [Related]
12. Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options.
Busse LW; Barker N; Petersen C
Crit Care; 2020 Feb; 24(1):36. PubMed ID: 32019600
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Vasopressin for Septic Shock in Patients on Chronic Renin-Angiotensin-Aldosterone System Inhibitors.
Erwin BL; Denaburg MA; Barker AB; McArdle PJ; Windham ST; Morgan CJ
Crit Care Med; 2017 Dec; 45(12):e1226-e1232. PubMed ID: 28991825
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II for Critically Ill Patients With Shock After Heart Transplant.
Cutler NS; Rasmussen BM; Bredeck JF; Lata AL; Khanna AK
J Cardiothorac Vasc Anesth; 2021 Sep; 35(9):2756-2762. PubMed ID: 32868151
[TBL] [Abstract][Full Text] [Related]
15. Use of Angiotensin II for Vasoplegic Shock in a Combined Heart and Liver Transplant Recipient with Systolic Anterior Motion Physiology.
Wieruszewski PM; Sims CR; Daly RC; Taner T; Wittwer ED
J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2366-2367. PubMed ID: 31076311
[No Abstract] [Full Text] [Related]
16. Determinants and Outcomes of Vasoplegia Following Left Ventricular Assist Device Implantation.
Tecson KM; Lima B; Lee AY; Raza FS; Ching G; Lee CH; Felius J; Baxter RD; Still S; Collier JDG; Hall SA; Joseph SM
J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773577
[TBL] [Abstract][Full Text] [Related]
17. Outcomes following the use of angiotensin II in patients with postoperative vasoplegic syndrome: A case series.
Konkol SB; Morrisette MJ; Hulse MC; Enfield KB; Mihalek AD
Ann Card Anaesth; 2022; 25(3):359-361. PubMed ID: 35799569
[TBL] [Abstract][Full Text] [Related]
18. The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia.
Papazisi O; Palmen M; Danser AHJ
Cardiovasc Drugs Ther; 2022 Aug; 36(4):739-748. PubMed ID: 33085026
[TBL] [Abstract][Full Text] [Related]
19. Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.
Bellomo R; Forni LG; Busse LW; McCurdy MT; Ham KR; Boldt DW; Hästbacka J; Khanna AK; Albertson TE; Tumlin J; Storey K; Handisides D; Tidmarsh GF; Chawla LS; Ostermann M
Am J Respir Crit Care Med; 2020 Nov; 202(9):1253-1261. PubMed ID: 32609011
[No Abstract] [Full Text] [Related]
20. Treatment of Renin-Angiotensin-Aldosterone System Dysfunction With Angiotensin II in High-Renin Septic Shock.
Chow JH; Wallis M; Lankford AS; Chancer Z; Barth RN; Scalea JR; LaMattina JC; Mazzeffi MA; McCurdy MT
Semin Cardiothorac Vasc Anesth; 2021 Mar; 25(1):67-73. PubMed ID: 32787515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
